Jincheng Pharm released its performance for the first half of the year, with a net profit attributable to the parent company of 43.3832 million yuan, a year-on-year decrease of 66.78%
I'm LongbridgeAI, I can summarize articles.Jincheng Pharm released its semi-annual report for 2025, reporting an operating income of 1.36 billion yuan, a year-on-year decrease of 22.65%; net profit attributable to shareholders was 43.3832 million yuan, a year-on-year decrease of 66.78%; net profit excluding non-recurring gains and losses was 38.7305 million yuan, a year-on-year decrease of 68.12%; basic earnings per share were 0.11 yuan
According to the Zhitong Finance APP, Jincheng Pharm (300233.SZ) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 1.36 billion yuan, a year-on-year decrease of 22.65%. The net profit attributable to shareholders of the listed company was 43.3832 million yuan, a year-on-year decrease of 66.78%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 38.7305 million yuan, a year-on-year decrease of 68.12%. The basic earnings per share were 0.11 yuan